EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Identification of a mosaic MTOR variant in purified neuronal DNA in a patient with focal cortical dysplasia using a novel depth electrode harvesting technique

Karl Martin Klein iD, Rumika Mascarenhas, Daria Merrikh, Maryam Khanbabaei, Tatiana Maroilley, Navprabhjot Kaur, Yiping Liu, Tyler Soule, Minette Manalo, Goichiro Tamura, Julia Jacobs, Walter Hader und 2 weitere

Epilepsia · 2024

DOI: 10.1111/epi.17980 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Epilepsia, 2024. Verfasst von Karl Martin Klein und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Malformations of Cortical Development, Neurons, Electroencephalography, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canada Foundation for Innovation, Epilepsy Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Recent studies have identified brain somatic variants as a cause of focal epilepsy. These studies relied on resected tissue from epilepsy surgery, which is not available in most patients. The use of trace tissue adherent to depth electrodes used for stereo electroencephalography (EEG) has been proposed as an alternative but is hampered by the low cell quality and contamination by nonbrain cells. Here, we use our improved depth electrode harvesting technique that purifies neuronal nuclei to achieve molecular diagnosis in a patient with focal cortical dysplasia (FCD).

Methods

Depth electrode tips were collected, pooled by brain region and seizure onset zone, and nuclei were isolated and sorted using fluorescence‐activated nuclei sorting (FANS). Somatic DNA was amplified from neuronal and astrocyte nuclei using primary template amplification followed by exome sequencing of neuronal DNA from the affected pool, unaffected pool, and saliva. The identified variant was validated using droplet digital polymerase chain reaction (PCR).

Results

An 11‐year‐old male with drug‐resistant genetic–structural epilepsy due to left anterior insula FCD had seizures from age 3 years. Stereo EEG confirmed seizure onset in the left anterior insula. The two anterior insula electrodes were combined as the affected pool and three frontal electrodes as the unaffected pool. FANS isolated 140 neuronal nuclei from the affected and 245 neuronal nuclei from the unaffected pool. A novel somatic missense MTOR variant (p.Leu489Met, CADD score 23.7) was identified in the affected neuronal sample. Droplet digital PCR confirmed a mosaic gradient (variant allele frequency = .78% in affected neuronal sample; variant was absent in all other samples). Significance Our findings confirm that harvesting neuronal DNA from depth electrodes followed by molecular analysis to identify brain somatic variants is feasible. Our novel method represents a significant improvement compared to the previous method by focusing the analysis on high‐quality cells of the cell type of interest.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malformations of Cortical DevelopmentNeuronsElectroencephalographyTOR Serine-Threonine KinasesHumansMaleChildDNADrug Resistant EpilepsyMosaicismEpilepsies, PartialFocal Cortical Dysplasia

Stichwörter der Autor:innen

epilepsyfocal cortical dysplasiageneticsmosaicsomatic

Substanzen

TOR Serine-Threonine KinasesMTOR protein, humanDNA

Autor:innen und Institutionen

  • Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
  • Department of Medical Genetics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
  • Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada.
  • Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
  • Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

ORCID-Profile: Karl Martin Klein

Förderung

  • CIHR
  • Canada Foundation for Innovation
  • Epilepsy Canada
  • Azrieli Foundation
  • Fondation Brain Canada
  • Health Canada
  • Canadian Institutes of Health Research

Zitieren

APA

Klein, K. M., Mascarenhas, R., Merrikh, D., Khanbabaei, M., Maroilley, T., Kaur, N., Liu, Y., Soule, T., Manalo, M., Tamura, G., Jacobs, J., Hader, W., Pfeffer, G., & Tarailo-Graovac, M. (2024). Identification of a mosaic MTOR variant in purified neuronal DNA in a patient with focal cortical dysplasia using a novel depth electrode harvesting technique. Epilepsia. https://doi.org/10.1111/epi.17980

Vancouver

Klein KM, Mascarenhas R, Merrikh D, Khanbabaei M, Maroilley T, Kaur N, et al. Identification of a mosaic MTOR variant in purified neuronal DNA in a patient with focal cortical dysplasia using a novel depth electrode harvesting technique. Epilepsia. 2024. doi:10.1111/epi.17980

BibTeX
@article{Klein2024,
  author = {Klein, Karl Martin and Mascarenhas, Rumika and Merrikh, Daria and Khanbabaei, Maryam and Maroilley, Tatiana and Kaur, Navprabhjot and Liu, Yiping and Soule, Tyler and Manalo, Minette and Tamura, Goichiro and Jacobs, Julia and Hader, Walter and Pfeffer, Gerald and Tarailo-Graovac, Maja},
  title = {Identification of a mosaic MTOR variant in purified neuronal DNA in a patient with focal cortical dysplasia using a novel depth electrode harvesting technique},
  journal = {Epilepsia},
  year = {2024},
  doi = {10.1111/epi.17980}
}
Kostenlos starten →